Tue, 24 Mar 2020
Local cancer patients undergoing active treatment are to have their treatment plans reviewed by their specialist teams as hospitals reconfigure their services to protect patients from infection, reduce attendances and manage rising demand.
The case-by-case review will mean some patients’ treatment plans may be changed while others are suspended or discontinued. Staff at Noble’s Hospital are linking with specialist teams at various UK hospitals to discuss the best treatment options, and patients will be contacted to discuss their risk and to advise them of the next steps.
New guidance from NHS England recommends that some chemotherapy and radiotherapy treatments should cease or be shortened and that outpatient consultations be replaced with telephone or telemedicine clinics. The measure is a clinical decision taken in the interests of patients, weighing the benefit of the therapy against the risk to patients with weakened immune systems of contracting, and being able to fight, Covid-19.
A video telemedicine link has been established between the Oncology Day Unit at Noble’s and Clatterbridge Cancer Centre for clinicians to liaise about patient care, as the situation evolves.
Those attending the Oncology unit at Noble’s for an appointment are asked to call the ward from their car before entering, and no one should arrive without an appointment.
Additionally, endoscopy procedures at Noble’s have been temporarily suspended to reduce the risk of patient infection. Patients currently referred for bowel or upper gastrointestinal investigations will have their case reviewed by a consultant, and telephone consultations will be offered where appropriate.
The Island’s breast screening programme has also been temporarily suspended. This follows a decision by the Greater Manchester Breast Screening Programme to suspend its services during the current outbreak.
The Greater Manchester operation administers the Isle of Man’s breast screening programme, providing letters and reporting, therefore the local imaging service cannot run. It is not possible to say at present when appointments will be rebooked.
Patients who have been recalled to a second assessment following their recent breast screening should attend as per their appointment letter. Patients with queries can call 642570 to leave a message and a member of the screening team will call them back.
Patients with questions about their revised cancer treatment plan should contact their clinical nurse specialist, and anyone who is concerned about potential symptoms of cancer should contact their GP as usual for advice and support.